Interestingly, Wnt/β-catenin activation due to overexpression of Wnt receptor FZD10 was associated with levantinib resistance [49]; also, Wnt/β-catenin activation induced GPX4 expression and ferroptosis resistance in gastric cancer [36]. This evidence concerns the gene GPX4 and gastric cancer.